Provenance
SPS national PGD templates for antimicrobial treatments are created by SPS, with support from the National Institute for Health and Care Excellence (NICE), the Royal College of General Practitioners (RCGP), the Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (ARPHAI), UK Health Security Agency (UKHSA) and NHS England (NHSE).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
Ceftriaxone for bacterial meningitis or meningococcal disease
A national PGD template for ceftriaxone for strongly suspected bacterial meningitis or strongly suspected meningococcal disease has not been developed by SPS. Further information is available via the following article:
Considerations for developing national PGD and protocol templates
Decisions to develop PGD templates under the national Medicines Governance Do Once Programme depend on a variety of factors and advice on exclusions is given.
More antimicrobial PGDs
- Trimethoprim for Urinary Tract Infection (UTI)
- Nitrofurantoin for Urinary Tract Infection (UTI)
- Permethrin for scabies
- Malathion for scabies
- Co-amoxiclav for human and animal bites
- Doxycycline and metronidazole for human and animal bites
- Valaciclovir for shingles
- Aciclovir for shingles
- Flucloxacillin for infected insect bites or stings
- Doxycycline for sinusitis
- Fluticasone furoate nasal spray for sinusitis
- Clarithromycin for sore throat
- Hydrogen peroxide 1% cream for impetigo
- Flucloxacillin for impetigo
- Clarithromycin for impetigo
- Clarithromycin for infected insect bites or stings
- Erythromycin for infected insect bites or stings
- Clarithromycin for otitis media
- Mometasone furoate monohydrate nasal spray for sinusitis
- Penicillin V (phenoxymethylpenicillin) for sinusitis
All PGD templates
National PGD, protocol and written instructions templates
National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Updated PGD template in line with updated NICE guidance NG240
- Anticipated publication date of NICE guidance updated from February 2024 to March 2024
- Expired template V1.1 removed - wording updated re anticipated publication of Version 2.0 pending updated NICE guidance publication.
- Page wording updated
- Revised wording regarding ceftriaxone
- Advisory text added regarding anticipated updated NICE guidance/impact on release of updated PGD templates.
- Title, URL and summary amended.
- Updated PGD template - expiry extended by 12 months to a total of 3 years.
- Published